PhytoHealth Corporation
TAI: 4108.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yi-Li Lee
- Employees
- 84
- Headquarters
- Taipei, Taiwan
- IPO year
- 2008
- Market cap
- NT$2.4B
- Website
- https://www.phytohealth.com.tw
Loading 4108…
Loading profile data…Frequently asked questions about 4108
What does PhytoHealth Corporation (4108.TW) do?
PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spi...
Where does 4108.TW trade?
PhytoHealth Corporation (4108.TW) trades on the Taiwan Stock Exchange.
What sector is 4108.TW in?
PhytoHealth Corporation (4108.TW) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of PhytoHealth Corporation?
Yi-Li Lee is the chief executive officer of PhytoHealth Corporation (4108.TW).
Where is PhytoHealth Corporation headquartered?
PhytoHealth Corporation is headquartered in Taiwan.
Does 4108.TW pay a dividend?
PhytoHealth Corporation (4108.TW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4108.TW go public?
PhytoHealth Corporation (4108.TW) completed its initial public offering in 2008.